AI in Pharma
Article
Rasayan Labs Emerges as a Unified AI Operating System for Generic Drug Development, Moving Beyond the Limits of Traditional Tools
Discover how Rasayan Labs is unifying AI-powered generic drug development with a single platform that accelerates API R&D, formula...
Other latest pieces about AI in Pharma you may like to read
Rasayan Labs Emerges as a Unified AI Operating System for Generic Drug Development, Moving Beyond the Limits of Traditional Tools
Discover how Rasayan Labs is unifying AI-powered generic drug development with a single platform that accelerates API R&D, formulation, regulatory workflows, and more.
by Team Pharma Now
AI Governance In Pharma: Is It Becoming The New GMP?
GMP built trust in physical manufacturing. Now algorithms need the same guardrails, here's why AI governance is following its playbook.
by Simantini Singh Deo
Can AI Decode the Gut? : Machine Learning in Microbiome Research
AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical reality.
by Dr. Nalini Raghunathan
How ML Virtual Screening Is Scaling Cancer Drug Targets?
ML virtual screening hits 18-45% in prospective trials vs sub-1% for HTS, unlocking undruggable cancer targets.
by Mrudula Kulkarni
Schrodinger vs. Insilico Medicine: A Comparison Report
Physics vs generative AI for cancer drug design. Schrodinger and Insilico Medicine compared pipeline, deals, and proof.
by Mrudula Kulkarni
